HOME Top Market Reports Biosurgery Market by Type (Surgical Sealants, Hemostatic Agents, Soft Tissue Attachments, Adhesion Barriers, Bone Graft Substitutes), Application (Neurological, Cardiovascular, General, Orthopedic, Reconstructive) - Global Forecast to 2020

Biosurgery Market by Type (Surgical Sealants, Hemostatic Agents, Soft Tissue Attachments, Adhesion Barriers, Bone Graft Substitutes), Application (Neurological, Cardiovascular, General, Orthopedic, Reconstructive) - Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: June 2015
Report Code: MD 3554

Discount on Reports  

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global biosurgery market is estimated to grow at a CAGR of 8.8% from 2015 to 2020, to reach $25,635.01 Million by 2020. The increasing rate of obesity and other lifestyle disorders leading to different kinds of surgeries, increasing participation in sports-related activities, growing aging population, and rising incidences of lower back and spinal disorders are the major factors driving the growth of the biosurgery market.

Surgical sealants and hemostatic agents are the most commonly used biosurgery products due to their wide applications in different types of surgeries. With the increasing trend of R&D investments, various new products are being launched in the market, such as antibiotic-coated tissue patches, which are expected to further propel market growth. However, high costs of surgical procedures and lack of reimbursements are major factors restraining the growth of this market during the forecast period.

In this report, the market of biosurgery is segmented by product, application, and region. On the basis of product type, the market is segmented into sealants, hemostatic agents, adhesion barriers, soft-tissue attachments, bone-graft substitutes, and staple-line reinforcement agents. On the basis of application, the market is segmented into neurological surgeries, cardiovascular surgeries, general surgeries, orthopedic surgeries, thoracic surgeries, gynecology surgeries, urology surgeries, and reconstructive surgeries.

Geographically, the market of biosurgery is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2014, North America commanded a major share of the biosurgery market; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the increasing government initiatives, improvement in the healthcare infrastructure, and rising disposable incomes.

Some of the prominent players in biosurgery market include Baxter International Inc. (U.S.), C.R. Bard (U.S.), Johnson & Johnson (U.S.), Covidien plc (Ireland), Sanofi Group (France), B. Braun Melsungen AG (Germany), Atrium Medical Corporation (U.S.), Cryolife, Inc. (U.S.), Stryker Corporation (U.S.), and Hemostasis, LLC (U.S.).

Scope of the Report

The biosurgery market includes the following segments:

By Product

  • Surgical Sealants
    • Fibrin Sealants
    • Synthetic Sealants/Cyanoacrylates
    • Collagen-based Compounds
    • Tissue Adhesives
  • Hemostatic Agents
  • Adhesion Barriers
  • Soft-tissue Attachments
    • Tissue Patch/Mesh
      • Synthetic Mesh
      • Biological Mesh
        • Allografts
        • Xenografts
  • Bone-graft Substitutes
    • Bone Allografts
    • Demineralized Bone Matrix (DBM)
    • Bone Morphogenetic Proteins (BMP)
    • Synthetic Grafts
  • Staple-line Reinforcement Agents

By Application

  • Neurological Surgeries
  • Cardiovascular Surgeries
  • General Surgeries
  • Orthopedic Surgeries
  • Thoracic Surgeries
  • Gynecology Surgeries
  • Urology Surgeries
  • Reconstruction Surgeries

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • Japan
    • India
    • China
    • Rest of Asia-Pacific (RoAPAC)
  • Rest of the World (RoW)
    • Latin America
    • Middle East and Africa

Table of Contents

1 Introduction (Page No. - 12)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 16)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
                    2.1.2.3 Breakdown of Primary Interviews
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 24)

4 Premium Insights (Page No. - 27)
    4.1 Growth Potential for the Market of Biosurgery  
    4.2 Asia-Pacific: Biosurgery Market, By Product (2014)
    4.3 Biosurgery Market: Geographic Growth Opportunities
    4.4 Biosurgery Market, Regional Mix
    4.5 Biosurgery Market: Developed vs Developing Countries

5 Market Overview (Page No. - 31)
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 By  Type
           5.2.2 By Application
    5.3 Market Dynamics
    5.4 Market Drivers
           5.4.1 Rising Number of Surgeries
           5.4.2 Increasing Incidence of Sports-Related Injuries and Spinal Problems
           5.4.3 Rapid Rise in Aging Population
    5.5 Market Restraints
           5.5.1 Little-To-No Reimbursements for Biosurgery
    5.6 Market Opportunities
           5.6.1 Improving Healthcare Systems in Emerging Markets With Growing Public & Private Investments
    5.7 Market Challenges
           5.7.1 High Price of Biosurgery & Rising Cost of Surgical Procedures

6 Industry Insights (Page No. - 40)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Growing Preference for Biological Meshes in Surgerical Procedures
           6.2.2 Increasing Acquisitions in Biosurgery Market Leads to Consolidation in the Market
    6.3 Porter’s Five Forces Analysis
           6.3.1 Threat From New Entrants
           6.3.2 Threat From New Substitutes
           6.3.3 Bargaining Power of Suppliers
           6.3.4 Bargaining Power of Buyers
           6.3.5 Intensity of Competitive Rivalry
    6.4 Strategic Benchmarking
           6.4.1 Product Portfolio Analysis: Biosurgery Market

7 Biosurgery Market, By Product (Page No. - 48)
    7.1 Introduction
    7.2 Surgical Sealants
           7.2.1 Fibrin Sealants
           7.2.2 Synthetic Agents/Cyanoacrylates
           7.2.3 Collagen-Based Sealants
           7.2.4 Tissue Adhesive Glues
    7.3 Hemostatic Agents
    7.4 Adhesion Barriers
    7.5 Soft-Tissue Attachments (Soft Tissue Patch/Mesh)
           7.5.1 Synthetic Mesh
           7.5.2 Biological Mesh
                    7.5.2.1 Allografts
                    7.5.2.2 Xenografts
    7.6 Bone Graft Subsitutes
           7.6.1 Bone Allografts
           7.6.2 Demineralized Bone Matrix (DBM)
           7.6.3 Bone Morphogenetic Proteins (BMP)
           7.6.4 Synthetic Bone Grafts
    7.7 Staple Line Reinforcement Agents

8 Biosurgery Market, By Application Key Findings (Page No. - 62)
    8.1 Introduction
    8.2 Neurological Surgeries
    8.3 Cardiovascular Surgeries
    8.4 General Surgeries
    8.5 Orthopedic Surgeries
    8.6 Thoracic Surgeries
    8.7 Gynecology Surgeries
    8.8 Urology Surgeries
    8.9 Reconstructive Surgeries

9 Biosurgery Market, By Geography Key Findings (Page No. - 70)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 U.K.
           9.3.3 France
           9.3.4 Italy
           9.3.5 Spain
           9.3.6 Rest of Europe (RoE)
    9.4 Asia-Pacific (APAC)
           9.4.1 Japan
           9.4.2 China
           9.4.3 India
           9.4.4 Rest of Asia-Pacific (ROAPAC)
    9.5 Rest of the World (RoW)
           9.5.1 Latin America
           9.5.2 Middle East and Africa

10 Competitive Landscape (Page No. - 90)
     10.1 Overview 
     10.2 Market Share of Biosurgery
             10.2.1 Sealants, Hemostatic Agents, Adhesion Barriers, and Staple-Line Reinforcement Agents
             10.2.2 Bone-Graft Substitutes
             10.2.3 Soft-Tissue Attachments (Tissue Patch/Mesh)
     10.3 Competitive Situation and Trends
             10.3.1 Mergers and Acquisitions
             10.3.2 Others
             10.3.3 Expansions
             10.3.4 New Product Launches
             10.3.5 Agreements, Partnerships, and Alliances

11 Company Profiles (Page No. - 103)
     11.1 Introduction
     11.2 Baxter International Inc.
             11.2.1 Business Overview
             11.2.2 Product Offerings
             11.2.3 Recent Developments
             11.2.4 SWOT Analysis
             11.2.5 MnM View
     11.3 Johnson & Johnson
             11.3.1 Business Overview
             11.3.2 Product Offerings
             11.3.3 Recent Developments
             11.3.4 SWOT Analysis
             11.3.5 MnM View
     11.4 C.R. BARD, Inc.
             11.4.1 Business Overview
             11.4.2 Products & Services
             11.4.3 Recent Developments
             11.4.4 SWOT Analysis
             11.4.5 MnM View
     11.5 Covidien PLC.
             11.5.1 Business Overview
             11.5.2 Product Offerings
             11.5.3 Recent Developments
             11.5.4 SWOT Analysis
             11.5.5 MnM View
     11.6 Sanofi Group
             11.6.1 Business Overview
             11.6.2 Product Offerings
             11.6.3 Recent Developments
             11.6.4 SWOT Analysis
             11.6.5 MnM View
     11.7 B. Braun Melsungen AG
             11.7.1 Business Overview
             11.7.2 Product Offerings
             11.7.3 Recent Developments
     11.8 Atrium Medical Corporation (A Part of Getinge Group)
             11.8.1 Business Overview
             11.8.2 Product Offerings
             11.8.3 Recent Developments
     11.9 Cryolife, Inc.
             11.9.1 Business Overview
             11.9.2 Product Offerings
             11.9.3 Recent Developments
     11.10 Hemostasis, LLC
             11.10.1 Business Overview
             11.10.2 Product Offerings
     11.11 Stryker Corporation
             11.11.1 Business Overview
             11.11.2 Product Offerings
             11.11.3 Recent Developments

12 Appendix (Page No. - 129)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Other Developments
     12.4 Introducing Rt: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports

*Details on Key Financials and Growth Strategy Might Not Be Captured in Case of Unlisted Companies.

List of Tables (83 Tables)

Table 1 Rising Number of Surgical Procedures & Increasing Number of Sports-Related Injuries Expected to Drive the Growth of the Biosurgery Market
Table 2 Little-To-No Reimbursements for Biosurgery to Hinder the Growth of the Market
Table 3 Improving Healthcare Systems in Emerging Markets for Biosurgery With Growing Investments Offer Significant Growth Opportunities
Table 4 High Price of the Biosurgery and Rising Cost of Surgical Procedures: Market Challenges
Table 5 Global Biosurgery Market Size, By Product, 2013–2020 ($Million)
Table 6 Global Biosurgery Market Size for Surgical Sealants, By Product Type, 2013–2020 ($Million)
Table 7 Global Surgical Sealants Market Size, By Country, 2013–2020 ($Million)
Table 8 Global Fibrin Sealants Market Size, By Country, 2013–2020 ($Million)
Table 9 Global Synthetic Agents/Cyanoacrylates Market Size, By Country, 2013–2020 ($Million)
Table 10 Global Collagen-Based Sealants Market Size, By Country, 2013–2020 ($Million)
Table 11 Global Tissue Adhesive Glues Market Size, By Country, 2013–2020 ($Million)
Table 12 Global Hemostatic Agents Market Size , By Country, 2013–2020 ($Million)
Table 13 Global Adhesion Barriers Market Size , By Country, 2013–2020 ($Million)
Table 14 Global  Soft-Tissue Patches/Meshes Market Size, By Product Type, 2013–2020 ($Million)
Table 15 Global Soft Tissue Patches/Meshes Market Size, By Country, 2013–2020 ($Million)
Table 16 Global Synthetic Mesh Market Size, By Country, 2013–2020 ($Million)
Table 17 Global Biological Mesh Market Size , By Product Type, 2013–2020 ($Million)
Table 18 Global Biological Mesh Market Size, By Country, 2013–2020 ($Million)
Table 19 Global Allografts Market Size , By Country, 2013–2020 ($Million)
Table 20 Global Xenografts Market Size , By Country, 2013–2020 ($Million)
Table 21 Global Bone Graft Substitutes Market Size, By Product Type, 2013–2020 ($Million)
Table 22 Global Bone Graft Substitutes Market Size, By Country, 2013–2020 ($Million)
Table 23 Global Bone Allografts Market Size, By Country, 2013–2020 ($Million)
Table 24 Global DBM Market Size, By Country, 2013–2020 ($Million)
Table 25 Global BMP Market Size, By Country, 2013–2020 ($Million)
Table 26 Global Synthetic Bone Grafts Market Size, By Country, 2013–2020 ($Million)
Table 27 Global Staple Line Reinforcement Agents Market Size, By Country, 2013–2020 ($Million)
Table 28 Global Biosurgery Market Size, By Application, 2013–2020 ($Million)
Table 29 Global Biosurgery Market Size for Neurological Surgeries, By Country/Region, 2013–2020 ($Million)
Table 30 Global Market Size for Cardiovascular Surgeries, By Country/Region, 2013–2020 ($Million)
Table 31 Global Biosurgery Market Size for General Surgeries, By Country/Region, 2013–2020 ($Million)
Table 32 Global Biosurgery Market Size for Orthopedic Surgeries, By Country/Region, 2013–2020 ($Million)
Table 33 Global Biosurgery Market Size for Thoracic Surgeries, By Country/Region, 2013–2020 ($Million)
Table 34 Global Biosurgery Market Size for Gynecology Surgeries, By Country/Region, 2013–2020 ($Million)
Table 35 Global Market Size for Urology Surgeries, By Country/Region, 2013–2020 ($Million)
Table 36 Global Market Size for Reconstructive Surgeries, By Country/Region, 2013–2020 ($Million)
Table 37 Global Biosurgery Market, By Region, 2013-2020 ($ Million)
Table 38 North America: Biosurgery Market Size, By Country, 2013-2020 ($ Million)
Table 39 North America: Market Size, By Product Type, 2013-2020 ($Million)
Table 40 North America: Biosurgery Market Size, By Application, 2013-2020 ($Million)
Table 41 U.S.: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 42 U.S.: Market Size, By Application, 2013-2020 ($Million)
Table 43 Canada: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 44 Canada: Biosurgery Market Size, By Application, 2013-2020 ($Million)
Table 45 Europe: Biosurgery Market Size, By Country, 2013-2020 ($ Million)
Table 46 Europe: Market Size, By Product, 2013-2020 ($Million)
Table 47 Europe: Market Size, By Application, 2013-2020 ($Million)
Table 48 Germany: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 49 Germany: Market Size, By Application, 2013-2020 ($Million)
Table 50 U.K.: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 51 U.K.: Market Size, By Application, 2013-2020 ($Million)
Table 52 France: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 53 France: Market Size, By Application, 2013-2020 ($Million)
Table 54 Italy: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 55 Italy: Market Size, By Application, 2013-2020 ($Million)
Table 56 Spain: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 57 Spain: Market Size, By Application, 2013-2020 ($Million)
Table 58 RoE: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 59 RoE: Market Size, By Application, 2013-2020 ($Million)
Table 60 APAC: Biosurgery Market Size, By Country, 2013-2020 ($ Million)
Table 61 APAC: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 62 APAC: Market Size, By Application, 2013-2020 ($Million)
Table 63 Japan: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 64 Japan: Biosurgery Market Size, By Application, 2013-2020 ($Million)
Table 65 China: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 66 China: Market Size, By Application, 2013-2020 ($Million)
Table 67 India: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 68 India: Market Size, By Application, 2013-2020 ($Million)
Table 69 ROAPAC: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 70 ROAPAC: Market Size, By Application, 2013-2020 ($Million)
Table 71 RoW: Biosurgery Market Size, By Country, 2013-2020 ($ Million)
Table 72 RoW: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 73 RoW: Biosurgery Market Size, By Application, 2013-2020 ($Million)
Table 74 Latin America: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 75 Latin America: Biosurgery Market Size, By Application, 2013-2020 ($Million)
Table 76 Middle East and Africa: Market Size, By Product, 2013-2020 ($Million)
Table 77 Middle East and Africa: Market Size, By Application, 2013-2020 ($Million)
Table 78 Growth Strategy Matrix, 2011 – 2015
Table 79 Mergers and Acquisitions, 2011 – 2015
Table 80 Others, 2011 – 2015
Table 81 Expansions, 2011 - 2015
Table 82 New Product Launches, 2011 – 2015
Table 83 Agreements, Partnerships, and Alliances, 2011 – 2015

List of Figures (35 Figures)

Figure 1 Global Biosurgery Market
Figure 2 Research Design for Biosurgery
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Global Biosurgery Market, By Product Type, 2015 vs 2020 ($ Million)
Figure 8 Global Biosurgery Products Market Size, By Application, 2015 vs 2020 ($ Million)
Figure 9 Geographical Snapshot of the Biosurgery Market, 2014
Figure 10 North America Dominated the Global Biosurgery Market in 2014
Figure 11 Rising Number of Surgeries to Drive Market Growth for Biosurgery
Figure 12 Soft-Tissue Attachment Market Accounted for Major Share of the Asia-Pacific Biosurgery Market
Figure 13 The U.S. Commanded the Largest Share of the Market of Biosurgery in 2014
Figure 14 North America to Dominate the Market of Biosurgery During the Forecast Period
Figure 15 Developing Markets to Register A Higher Growth During the Forecast Period
Figure 16 Market Segmentation of Biosurgery, By  Type
Figure 17 Market Segmentation of Biosurgery, By Application
Figure 18 Biosurgery Market: Drivers, Restraints, Opportunities, & Challenges
Figure 19 Demographic Growth Trends of the Elderly Population
Figure 20 Increasing Trend Towards Use of Biological Meshes and Acquisitions By Major Players Leading to Rising Consolidations in Biosurgery Market
Figure 21 Companies Adopted Expansions as Their Key Growth Strategy
Figure 22 Global Sealants, Hemostatic Agents, Adhesion Barriers, and Staple-Line Reinforcement Market Share Analysis, By Key Players, 2014
Figure 23 Global Bone Graft-Substitutes Market Share Analysis of Biosurgery, By Key Players, 2014
Figure 24 Global Soft-Tissue Repair Market Share Analysis of Biosurgery, By Key Player, 2014
Figure 25 Battle for Market Share of Biosurgery: Mergers and Acquisitions Was the Key Strategy Adopted By Prominent Players
Figure 26 Geographic Revenue Mix of Major Players
Figure 27 Company Snapshot: Baxter International Inc.
Figure 28 Company Snapshot: Johnson & Johnson
Figure 29 Company Snapshot: C.R. BARD, Inc.
Figure 30 Company Snapshot: Covidien PLC.
Figure 31 Company Snapshot: Sanofi Group
Figure 32 Company Snapshot: B. Braun Melsungen AG
Figure 33 Company Snapshot: Getinge Group
Figure 34 Company Snapshot: Cryolife, Inc.
Figure 35 Company Snapshot: Stryker Corporation

The global biosurgery market is expected to reach $25,635.01 Million by 2020 from $16,835.28 Million in 2015, at a CAGR of 8.8% during the forecast period of 2015 to 2020. Growth in the market of biosurgery is majorly driven by the increasing number of surgeries owing to the rising incidences of obesity and lifestyle disorders, growing aging population, and increasing number of sports-related injuries and spinal disorders.

In this report, the market of biosurgery is segmented by product and application. On the basis of products, the market is segmented into sealants, hemostatic agents, adhesion barriers, soft-tissue attachments, bone-graft substitutes, and staple-line reinforcement agents. On the basis of application, the market of biosurgery is segmented into neurological surgeries, cardiovascular surgeries, general surgeries, orthopedic surgeries, thoracic surgeries, gynecology surgeries, urology surgeries, and reconstructive surgeries.

North America commanded the largest share of the biosurgery market, followed by Europe; however, both these regions are expected to grow at a sluggish rate owing to market saturation. On the other hand, the Asia-Pacific and RoW (Latin America) regions are expected to witness high growth owing to improvement of the healthcare infrastructure in these regions, presence of a large patient pool, rising disposable incomes, and growing government investments.

The major players operating in this market include Baxter International Inc. (U.S.), C.R. Bard (U.S.), Johnson & Johnson (U.S.), Covidien plc (Ireland), Sanofi Group (France), B. Braun Melsungen AG (Germany), Atrium Medical Corporation (U.S.), Cryolife, Inc. (U.S.), Stryker Corporation (U.S.), and Hemostasis, LLC (U.S.). Mergers and acquisitions, expansions, and new product launches are some of the key strategies adopted by players in the biosurgery market.

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Bioimplants, Neurostimulation Markets on KnowledgeStore
Request Demo